## Lambert-Eaton Myasthenic Syndrome (LEMS): Presynaptic Calcium Channel Dysfunction ### Pathophysiology of Incremental Response **Key Point:** LEMS is caused by IgG autoantibodies against voltage-gated calcium channels (VGCC), predominantly P/Q-type channels at the presynaptic motor nerve terminal. These antibodies reduce the number of functional calcium channels, impairing calcium influx and acetylcholine release. ### Why High-Frequency Stimulation Restores Function **High-Yield:** The incremental response occurs because: 1. **At rest (low-frequency stimulation):** Reduced calcium influx → insufficient acetylcholine release → small EPPs → subthreshold muscle response 2. **During high-frequency stimulation:** - Repeated depolarizations cause cumulative calcium entry through remaining functional channels - Intracellular calcium concentration rises progressively - Enhanced acetylcholine mobilization and release from reserve pools - EPP amplitude increases with successive stimuli → eventually reaches threshold - Muscle action potentials fire → CMAP amplitude increases **Clinical Pearl:** This is the opposite of myasthenia gravis (postsynaptic), where repetitive stimulation causes fatigue (decremental response). LEMS shows **incremental increase** in CMAP amplitude with high-frequency RNS—a diagnostic hallmark. ### Mechanism Diagram ```mermaid flowchart TD A[Low-frequency stimulation]:::action --> B[Reduced VGCC function due to antibodies] B --> C[Limited Ca²⁺ influx] C --> D[Insufficient ACh release] D --> E[Small EPP amplitude]:::outcome E --> F[Subthreshold response] G[High-frequency stimulation]:::action --> H[Cumulative Ca²⁺ entry through remaining channels] H --> I[Intracellular Ca²⁺ accumulation] I --> J[Enhanced ACh mobilization from reserve pool] J --> K[Increased EPP amplitude]:::outcome K --> L[Suprathreshold response - CMAP increases]:::action ``` ### Comparison: MG vs LEMS | Feature | MG (Postsynaptic) | LEMS (Presynaptic) | |---------|-------------------|-------------------| | **Antibody target** | AChR | VGCC (P/Q-type) | | **RNS response** | Decremental (↓) | Incremental (↑) | | **CMAP amplitude** | Normal or low | Low at baseline | | **Autonomic features** | Absent | Prominent (dry mouth, impotence) | | **Associated malignancy** | Rare | SCLC (50–60%) | | **Proximal vs ocular** | Ocular often first | Proximal always | **Mnemonic: LEMS = Low at baseline, Enhances with high frequency, Malignancy-associated, SCLC** [cite:Harrison 21e Ch 385; Robbins 10e Ch 27]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.